RT @1stOncology: #AuraBiosciences Announces Dosing of First Patient in Phase 2 S…
[ad_1]
RT @1stOncology: #AuraBiosciences Announces Dosing of First Patient in Phase 2 Study Evaluating Suprachoroidal Administration of #AU011 in…
[ad_2]
Source by Thomas Ciulla, MD, MBA